CompanyGraph
Chongqing Xishan Science & Technology Co. Ltd.
688576 · SSE · China
xishantech.com.cnFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionOperating margin is -88.1%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)
- FinancialsAltman Z-Score 10.82: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.25%
Annual Rate
CNY 0.50Paid annual
Payout Ratio
92.6%High
Payback Period
79.7 yr
Last Ex-Dividend
Jun 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.73BCNY407.22M · vs all stocks (USD)
Revenue (TTM)
306.53MCNY45.76M · vs all stocks (USD)
Profit Margin
-2.59%vs Medical Instruments & Supplies peers
Beta
1.01xvs all stocks
52-Week Change
-8.23%vs all stocks
Market Capitalization
2.73BCNY407.22M · vs all stocks (USD)
Enterprise Value
1.54BCNY230.03M · vs all stocks (USD)
Forward P/E
9.08xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
8.87xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.58xvs Medical Instruments & Supplies peers
Enterprise to Revenue
5.03xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-155.79xvs Medical Instruments & Supplies peers
Gross Margin
57.50%vs Medical Instruments & Supplies peers
Profit Margin
-2.59%vs Medical Instruments & Supplies peers
Operating Margin
-88.15%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-1.16%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-0.47%vs Medical Instruments & Supplies peers
Revenue (TTM)
306.53MCNY45.76M · vs all stocks (USD)
Revenue per Share (TTM)
4.57CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-46.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
172.95MCNY25.82M · vs all stocks (USD)
EBITDA (TTM)
69.93MCNY10.44M · vs all stocks (USD)
Net Income (TTM)
-7.94MCNY-1.18M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-27.52%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
-9.53MCNY-1.42M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-95.12MCNY-14.20M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.5000CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
1.25%vs all stocks
Payout Ratio
92.59%vs Medical Instruments & Supplies peers
Revenue
341.99MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
124.14MCNYFY2025 · Dec 31, 2025Gross Profit
217.85MCNYFY2025 · Dec 31, 2025Operating Income
40.33MCNY6.02M · vs all stocks (USD)
Pre-tax Income
53.09MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.18MCNYFY2025 · Dec 31, 2025Net Income
51.91MCNYFY2025 · Dec 31, 2025EBIT
40.33MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
69.93MCNYFY2025 · Dec 31, 2025Research & Development
58.08MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
56.35MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.02MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7718CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7718CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
67.25MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
67.25MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
51.91MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-18.52MCNYFY2025 · Dec 31, 2025Free Cash Flow
-114.35MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
289.08MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
51.91MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.39MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-4.60MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-67.22MCNYFY2025 · Dec 31, 2025Capital Expenditures
-95.83MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.64BCNYFY2025 · Dec 31, 2025Sale of Investments
1.50BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-236.75MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-45.19MCNYFY2025 · Dec 31, 2025Other Financing Charges
-47.20MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-92.39MCNYFY2025 · Dec 31, 2025Shares Outstanding
67.64MSharesUpdated Sep 22, 2026Float Shares
38.27MSharesUpdated Sep 22, 2026% Held by Insiders
60.83%vs all stocks
% Held by Institutions
7.42%vs all stocks
Total Cash (MRQ)
1.15BCNY171.90M · vs all stocks (USD)
Total Cash per Share (MRQ)
17.14CNYUpdated Sep 22, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
11.85xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
25.45CNYUpdated Sep 22, 2026Total Assets
1.90BCNY283.41M · vs all stocks (USD)
Total Current Assets
1.45BCNYFY2025 · Dec 31, 2025Total Liabilities
170.74MCNYFY2025 · Dec 31, 2025Total Non-current Assets
445.65MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
7.71MCNYFY2025 · Dec 31, 2025Total Current Liabilities
163.04MCNYFY2025 · Dec 31, 2025Cash
285.16MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.92MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
289.08MCNYFY2025 · Dec 31, 2025Other Short-term Investments
436.02MCNYFY2025 · Dec 31, 2025Accounts Receivable
39.05MCNYFY2025 · Dec 31, 2025Inventory
134.39MCNYFY2025 · Dec 31, 2025Accounts Payable
121.42MCNYFY2025 · Dec 31, 2025Other Current Liabilities
2.50MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
6.68MCNYFY2025 · Dec 31, 2025Common Stock (Book)
45.50MCNYFY2025 · Dec 31, 2025Retained Earnings
227.94MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.73BCNY257.93M · vs all stocks (USD)
Treasury Stock
23.61MCNYFY2025 · Dec 31, 202552-Week Low
34.83CNYUpdated Sep 22, 202652-Week High
58.83CNYUpdated Sep 22, 202652-Week Change
-8.23%vs all stocks
Beta
1.01xvs all stocks
50-Day MA
39.35CNYUpdated Sep 22, 2026200-Day MA
45.76CNYUpdated Sep 22, 2026Avg 10-Day Volume
331.28KSharesUpdated Sep 22, 2026Avg 30-Day Volume
375.27KSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.1200CNYUpdated Sep 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -88.1%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -0.88Industry median: 0.12Industry P5: -0.14Peers compared: 62.00
Current ratio is 11.85×, higher than 95% of its Medical Instruments & Supplies peers (median 2.2×)Significant
Current ratio: 11.85Industry median: 2.20Industry P95: 10.55Peers compared: 62.00
Debt-to-equity is 0×, lower than 95% of its Medical Instruments & Supplies peers (median 0.23×)Notable
Debt-to-equity: 0.00Industry median: 0.23Industry P5: 0.00Peers compared: 62.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.58Profit Margin: -0.03
Financial Health
Altman Z-Score 10.82: safe zoneNotable
Altman Z-Score: 10.82
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Kuo Toong International Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Lianming Machinery Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Glory Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hota Industrial Manufacturing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hangzhou Everfine Photo-E Info Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Terasaki Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Guangdong PAK Corp Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
XDC Industries (Shenzhen) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Oiles Corporation
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Uniparts India Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Global-E Online Ltd.
2 interpretationsMulti-Year Revenue And Profit GrowthMinimal Tax and Interest Drag
Grupo Mateus S.A.
2 interpretationsMulti-Year Revenue And Profit GrowthMinimal Tax and Interest Drag
Siglent Technologies Co., Ltd.
2 interpretationsMulti-Year Revenue And Profit GrowthMinimal Tax and Interest Drag